Orbis Allan Gray Ltd

Q1 2023 13F-HR Detailed Holdings

Location
Hamilton, D0
Holdings as of
3/31/2023
Date filed
5/15/2023
Form type
13F-HR
Num holdings
130
Total value ($000)
$12,717,561
Net value change ($000)
+123,038 (1.0%)
New positions
7
Sold out positions
13
Turnover %
7.2%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 2/14/2023 Next filing: 8/14/2023 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q4 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
IBKR 284,319 92.6%
CPAY 187,531 21.2%
MU 171,258 757.6%
GXO 161,473 25.1%
WBD 147,400 NEW
NE 136,414 NEW
TSM 124,809 26.0%
RIG 111,278 NEW
VAL 107,229 44.8%
CNK 94,460 124.1%
Top Reduces (Value $000, Stocks/ETFs)
BTI -259,708 -51.1%
NTES -185,603 -55.5%
DG -174,470 -96.4%
SLB -147,996 -74.2%
EXE -131,043 -43.1%
Arconic Corp -116,166 -100.0%
LNG -110,085 -100.0%
RNR -109,003 -71.1%
GOOGL -106,377 -17.9%
UNH -84,243 -22.5%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 ORBIS INVESTMENT MANAGEMENT LTD 028-04613
2 Orbis Investment Management (U.S.), L.P. 028-15939